The possible diagnostic and prognostic use of systemic chemokine profiles in clinical medicine—the experience in acute myeloid leukemia from disease development and diagnosis via conventional chemotherapy to allogeneic stem cell transplantation.
about
Acute graft-versus-host disease: a bench-to-bedside update.Preconditioning serum levels of endothelial cell-derived molecules and the risk of posttransplant complications in patients treated with allogeneic stem cell transplantationSpecific molecular signatures predict decitabine response in chronic myelomonocytic leukemia.The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation.Systematic evaluation of immune regulation and modulationThe snake venom rhodocytin from Calloselasma rhodostoma- a clinically important toxin and a useful experimental tool for studies of C-type lectin-like receptor 2 (CLEC-2)Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies.Cytokine Release Patterns in Mixed Lymphocyte Culture (MLC) of T-Cells with Dendritic Cells (DC) Generated from AML Blasts Contribute to Predict anti-Leukaemic T-Cell Reactions and Patients' Response to Immunotherapy.Mesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular MechanismsThe prognostic significance of serum XCL1 concentration in patients with acute lymphoblastic leukemia: a pilot study.The role of cytokines and chemokines in the microenvironment of the blood-brain barrier in leukemia central nervous system metastasis.Increased antileukemic effects in human acute myeloid leukemia by combining HSP70 and HSP90 inhibitors.Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism.
P2860
Q27687130-AF793EF8-C281-406C-9EB2-6BA1B21FF460Q34390721-432E6EDA-C96A-4F2D-842B-67F1A39F736EQ36179524-FF93DF71-B05C-4361-84D7-77BCC1C2334AQ37366244-A4F78638-41E2-4F2C-916A-F63A3A874350Q37713498-121223F7-825C-401B-B6CB-D28F6FE6AA32Q38099700-6A236312-F05E-44EC-932A-2028A7D801EAQ38226527-8BFAF7C3-C638-4FDD-86CD-BBE374926AB2Q39414681-B6E83CEC-59CA-47FE-A744-06FF2C8B2896Q42262053-2F30125D-04C3-4610-85F5-5659BBCFF54BQ47658796-A13AB89C-6287-4C7C-B87C-D5A201E34B21Q50325439-B10FAFBA-0BDA-4993-A5F5-D1F9B9293154Q51068076-A45B7F1A-DF0E-4E64-B09B-DDFF22DE3CA6Q51102707-F14D680E-916C-418F-9848-A1766CA2B938
P2860
The possible diagnostic and prognostic use of systemic chemokine profiles in clinical medicine—the experience in acute myeloid leukemia from disease development and diagnosis via conventional chemotherapy to allogeneic stem cell transplantation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The possible diagnostic and pr ...... eic stem cell transplantation.
@en
type
label
The possible diagnostic and pr ...... eic stem cell transplantation.
@en
prefLabel
The possible diagnostic and pr ...... eic stem cell transplantation.
@en
P2093
P2860
P921
P356
P1433
P1476
The possible diagnostic and pr ...... eic stem cell transplantation.
@en
P2093
Astrid Olsnes Kittang
Hanne Fredly
Håkon Reikvam
Oystein Bruserud
P2860
P304
P356
10.3390/TOXINS5020336
P5008
P577
2013-02-18T00:00:00Z